Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
stent (TXC702) if "heart" or "coronary"
cardiomyopathy (DXC280), cardiomegaly (DXC590), congestive heart failure (DXC282), cor pulmonale (DXC443), mitral valve regurgitation, prolapse and stenosis (DXC446-DXC448), aortic valve stenosis (DXC452), aortic valve regurgitation (DXC453), tricuspid valve regurgitation (DXC454), cardiac arrhythmias (DXC480), right ventricular heart failure (DXC482), endocarditis (DXC573), myocarditis (DXC549), pulmonary hypertension (DXC389)
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
Fasting labs – one required Use of the following treatments for at
insulin (TXC287), Glucotrol (TXC541), category
glucose 2-hour test result (LXC443) > 200 mg/dL or
≥11 mmol/l Non-fasting (random) labs – two required: Glucose (LXC208) > 200 mg/dL HGBA1C (LXC484)
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
glucose 2-hour test result (LXC443) in 140-200 mg/dL range or 7.7 to <11 mmol/l range Non-fasting (random) labs – two required: glucose (LXC208) in 140- 200 mg/dL range or 7.7 to <11 mmol/l range any single HGBA1C (LXC484) ≥ 6.5% without a normal glucose within 90 days of the HGBA1C measurement (before of after)
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
Aldomet (TXC483), Aldoril (TXC484), Calan (TXC487), Capoten (TXC488), Levatol (TXC489), Cardizem (TXC490), Catapres (TXC492), Lopressor (TXC493), Lotensin (TXC494), Norvasc (TXC497), Plendil (TXC498), Zestril (TXC499), Ziac (TXC500), Other hypertensive 2 (TXC624), Nifedipine (TXC618), Other hypertensive 3 (TXC649)
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
Vytorin (TXC737), Advicor (TXC738), Lovaza (TXC798), Caduet (TXC753) or Vitamins/supplements/other alternate therapy (TXC123, TXC124) if “omega”, “fish”, or “omacor” in tx_othde.
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
Hep BE Antigen (LXC460), Hep B viral load (LXC726 & LXC465) Hep B core Ag (LXC467) Hep C genotype (LXC517) Hep B core Ab (LXC463)
-----------------------------------------------
Hep B core Ag (LXC467) Hep C genotype (LXC517) Hep B core Ab (LXC463)
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
codes in the category 6 “Viral hepatitis B exclude the presence of
include codes for elevated transaminases (DXC465) or hepatic insufficiency (DXC464) – not specific enough.
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
history of ever smoking (current, former)
DXC633 and “cig” or “tobacco” in
Albuterol/Ipratropium = Combivent (TXC533)
Exclude if around the time of pregnancy
Buchacz et al. Algorithm for coding chronic disease conditions based on diagnoses, laboratory values and treatments in the HOPS study of HIV-infected patients – for results in manuscript Tables 2 and 3. Codes in parentheses indicate HOPS house-codes used in data abstraction. Condition
Testicular (DXC530), Anal/rectal (DXC581), Colon (DXC598), Thyroid (DXC634), Esophageal (DXC635), Renal (DXC636), Pancreatic (DXC637), Leukemia (DXC638), Stomach/GI (DXC639), Other (DXC148)
Uncle Fester - The Father of Home Cooked Methamphetamine If Albert Hofmann was the "Father Of LSD," it's probably appropriate to call Steve Preisler the "Father Of Modern Meth-Making." "Uncle Fester" is the pseudonym, or "pen name," used by Steve Preisler to write his books. In the early 1980's, he gained cult status after publishing his first book "Secrets o
O setor de biofármacos e as oportunidades para o BrasilBiopharmaceutical sector and opportunities for BrazilLucídio Cristóvão Fardelone*Bruna Ângela Branchi**O presente artigo analisa o setor de biofármacos. Inicia-se com umacomparação entre as vendas deste setor e do setor farmacêutico no mundo,a partir de 2000, identificando, após, as principais empresas e a evoluçãodas relativas